Hyrimoz 40 mg solution for injection in pre-filled syringe
Sponsors
Diakonhjemmet Sykehus AS, University Of Medicine And Pharmacy Carol Davila Bucharest, Medical University Of Vienna, Karolinska University Hospital, Universiteit Maastricht
Conditions
Crohn's diseaseRheumatoid arthritis
Phase 4
A multi-center, open, randomized, 18-month, parallel-group, superiority study to compare the effect of proactive therapeutic drug monitoring versus standard of care with regards to maintenance of sustained disease control without flare in adults with rheumatoid arthritis treated with a subcutaneous tumor necrosis factor inhibitor
RecruitingCTIS2023-510184-35-00
Start: 2024-08-20Target: 410Updated: 2025-09-12
Control Crohn Safe with episodic adalimumab monotherapy as first line treatment study
RecruitingCTIS2024-516002-33-01
Start: 2019-12-23Target: 158Updated: 2024-12-17